| Dr Sarah Y Won, MD | |
|
1653 W Congress Pkwy, Chicago, IL 60612-3833 | |
| (312) 942-3665 | |
| Not Available |
| Full Name | Dr Sarah Y Won |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 21 Years |
| Location | 1653 W Congress Pkwy, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790982932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 036-116129 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush University Medical Center | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.
Young first- and second-degree relatives of individuals who were victims of sudden cardiac death are at a significantly increased risk for developing cardiovascular disease, research suggests.
Mississippi State University will be the first higher learning institution in the nation to partner with the U.S. Department of Veterans Affairs to provide timely, specialized health benefits to veterans.
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases.
› Verified 3 days ago
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.
Young first- and second-degree relatives of individuals who were victims of sudden cardiac death are at a significantly increased risk for developing cardiovascular disease, research suggests.
Mississippi State University will be the first higher learning institution in the nation to partner with the U.S. Department of Veterans Affairs to provide timely, specialized health benefits to veterans.
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases.
› Verified 3 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.
Young first- and second-degree relatives of individuals who were victims of sudden cardiac death are at a significantly increased risk for developing cardiovascular disease, research suggests.
Mississippi State University will be the first higher learning institution in the nation to partner with the U.S. Department of Veterans Affairs to provide timely, specialized health benefits to veterans.
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases.
› Verified 3 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518196138 PECOS PAC ID: 8628114956 Enrollment ID: O20090930000174 |
News Archive
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.
Young first- and second-degree relatives of individuals who were victims of sudden cardiac death are at a significantly increased risk for developing cardiovascular disease, research suggests.
Mississippi State University will be the first higher learning institution in the nation to partner with the U.S. Department of Veterans Affairs to provide timely, specialized health benefits to veterans.
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Y Won, MD 6648 N Rockwell St, Chicago, IL 60645-5023 Ph: (773) 818-9462 | Dr Sarah Y Won, MD 1653 W Congress Pkwy, Chicago, IL 60612-3833 Ph: (312) 942-3665 |
News Archive
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.
Young first- and second-degree relatives of individuals who were victims of sudden cardiac death are at a significantly increased risk for developing cardiovascular disease, research suggests.
Mississippi State University will be the first higher learning institution in the nation to partner with the U.S. Department of Veterans Affairs to provide timely, specialized health benefits to veterans.
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases.
› Verified 3 days ago
Dr. Sorin C Danciu, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |